MercoPress16h
Brazil's Anvisa approves weekly insulin to treat diabetes 1 and 2
Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...
pharmaphorum2d
FDA rejects Novo Nordisk’s weekly basal insulin
Awiqli has been cleared for both types of diabetes in all its current markets except China, where it can be used for type 2 only. “We believe in the potential of once-weekly basal insulin icodec ...
GlobalData on MSN11mon
EMA CHMP recommends Novo Nordisk’s weekly insulin for diabetes
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation ...
Zacks.com on MSN5mon
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?
Awiqli is currently approved in the EU, Canada, Australia, Japan and China for type I diabetes. The decline in the stock ...